Wockhardt Ltd


BSE: 532300 | NSE: WOCKPHARMA | ISIN: INE049B01025 
Market Cap: [Rs.Cr.] 8,617 | Face Value: [Rs.] 5
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Board Meet

22-May-12 
Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2012, inter alia, to consider and approve the audited financial results of the Company for the quarter and year ended March 31, 2012. Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2012, inter alia, to consider the recommendation of dividend @ 0.01% (Rs. 0.0005 per preference share of Rs. 5/- each) on Non-Convertible Cumulative Redeemable Preference shares of Rs. 5/- each and Optionally Convertible Cumulative Redeemable Preference Shares of Rs. 5/- each absorbing a sum of Rs. 21.75 lakhs, on cumulative basis. (As Per BSE Announcement Dated on 18.05.2012) Wockhardt Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2012 inter alia, has recommended dividend @ 0.01% (Rs. 0.0005 per preference share of Rs. 5/- each) absorbing a sum of Rs. 21,75,171/- and dividend distribution tax of Rs. 3,52,867/-, on cumulative basis, on 107,61,98,988 Non-Convertible Cumulative Redeemable Preference shares of Rs. 5/- each and 44,65,49,949 optionally Convertible Cumulative Redeemable Preference Shares of Rs. 5/- each out of the net profits of the Company as per the provisions of section 205 of the Companies Act, 1956.The dividend, if declared at the Annual General Meeting, will be paid within 30 days from the date of Annual General Meeting. (As Per BSE Announcement Website dated on 22/05/2012) 
13-Feb-12 
Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2012, inter-alia to consider and approve the Un-audited Financial results of the Company for the quarter and nine months ended December 31 , 2011 (Q3). 
12-Nov-11 
Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 12, 2011, inter-alia to consider and approve the Un-audited Financial results of the Company for the quarter and half year ended September 30 , 2011. Wockhardt Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2011, inter alia, has approved the Grant of 1,540,000 Stock Options convertible into 1,540,000 equity shares of Rs. 5/- each (60,000 options @ Rs. 397/- per option; 60,000 options @ Rs. 365/- per option; 1,420,000 options @ Rs. 5/- per option) under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, to the selected employees of the Company and its subsidiaries. (As Per BSE Announcement Website Dated on 12/11/2011) 
09-Aug-11 
Quarterly Results Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 09, 2011, inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2011 and may also consider implementation of Employees Stock Option Scheme. (As Per BSE Announcement Dated on 04.08.2011) Wockhardt Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2011, inter alia, considered and approved Employee Stock option Scheme - 2011 (Wockhardt ESOS - 2011) and issuance of 25,00,000 stock options to the permanent bonafide employees and directors of the Company and its Holding and Subsidiary Company under Wockhardt ESOS - 2011. Each option covers one equity share and thus aggregate number of 25,00,000 equity shares of face value of Rs. 5/- each are covered under Woclchardt ESOS - 2011. The said issuance of ESOP will be subject to the approval of the members of the Company. (As Per BSE Announcement Website dated on 09.08.2011) 
19-May-11 
Audited Results Wockhardt Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2011, inter alia, Mr. Vijay Khetan has been appointed as Company Secretary of the Company w.e.f. May 19, 2011 and Mr. Jayant Manmadkar has resigned from the position of Company Secretary of the Company w.e.f. May 19, 2011. (As Per BSE Announcement Website dated on 19.05.2011) 

AGM

12-Sep-11
AGM 12/09/2011 Wockhardt Ltd has informed BSE that the members at the 12th Annual General Meeting (AGM) of the Company held on September 12, 2011, inter alia, have passed the following: 1. Adoption of Audited Balance Sheet as at March 31, 2011, Profit and Loss Account for the fifteen months period ended on that date and the Reports of the Board of Directors and Auditors thereon. 2. Re-appointment of Mr. Shekhar Datta as a Director of the Company, 3. Re-appointment of Dr. Huzaifa Khorakiwala as a Director of the Company. 4. Appointment of M/s. Haribhakti Co., Chartered Accountants as the Statutory Auditors of the Company to hold office from the conclusion of this meeting till the conclusion of next Annual General Meeting of the Company. 5. Grant, offer, issue and allot not exceeding 2,500,000 options convertible into equity shares of face value of 5/- each to permanent employees (present and future) of the Company and Directors, as may be decided by the Board under Wockhardt Employee Stock Option Scheme - 2011 ('ESOP Scheme'). 6. Grant, offer, issue and allot options convertible into equity shares of the Company to eligible employees or directors of the subsidiary companies and / or Holding Company of the Company, as may be decided by the Board under Wockhardt Employee Stock Option Scheme - 2011 ('ESOP Scheme'). (As Per BSE Announcement Website dated on 13.09.2011) 
20-Sep-10
AGM 20/09/2010 Wockhardt Ltd has informed BSE that the members at the 11th Annual General Meeting (AGM) of the Company held on September 20, 2010, inter alia, have passed the following resolutions unanimously: 1. Adoption of Audited Balance Sheet as at March 31, 2010, Profit and Loss Account for the fifteen months period ended on that date and the Reports of the Board of Directors and Auditors thereon. 2. Re- appointment of Mr. Aman Mehta as a Director of the Company. 3. Re-appointment of Mr. Bharat Patel as a Director of the Company, 4. Appointment of M/s Haribhakti & Co., Chartered Accountants as the Statutory Auditors of the Company to hold office from the conclusion of this meeting till the conclusion of next Annual General Meeting of the Company. 5. Re-appointment of Mr. H. F. Khorakiwala as Chairman of the Company, for a period of 5 (five) years with effect from March 01, 2010 and payment of remuneration as provided in the resolution. (As Per BSE Announcement Website dated on 21.09.2010) 
29-Jun-09
AGM 29/06/2009 Wockhardt Ltd has informed BSE that the members at the 10th Annual General Meeting (AGM) of the Company held on June 29, 2009, inter alia, have accorded to the following: 1. Adoption of Audited Balance Sheet as at December 31, 2008, Profit and Loss Account for the year ended on that date and the Reports of the Board of Directors and Auditors thereon. 2. Re-appointment of Dr. Abid Hussain as a Director of he Company. 3. Re-appointment of Mr. R A Shah as a Director of the Company. 4. Appointment of M/s Haribhakti & Co, Chartered Accountants as the Statutory Auditors of the Company to hold office till the conclusion of next Annual General Meeting of the Company. 5. Approval for the remuneration paid to Mr. Habil F Khorakiwala, Executive Chairman of the Company during the period January 01, 2008 to December 31, 2008. 6. Approval for the payment of remuneration to Mr. Habil F Khorakiwala, Executive Chairman of the Company for a period of three financial years in his tenure in which there is inadequacy or absence of profits starting from the financial year January 01, 2009. Such payment of remuneration is subject to the approval of Central Government. 7. Appointment of Mr. Huzaifa H Khorakiwala as a Director of the Company, liable to retire by rotation. 8. Appointment of Mr. Huzaifa H Khorakiwala as a Whole-time Director designated as 'Executive Director' of the Company for a period of five years w.e.f. March 31, 2009 and approval for the payment of remuneration to Mr. Huzaifa H Khorakiwala, Executive Director of the Company. 9. Appointment of Dr. Murtaza H Khorakiwala as a Director of the Company, liable to retire by rotation. 10. Appointment of Dr. Murtaza H Khorakiwala as a Managing Director of the Company for a period of five years w.e.f. March 31, 2009 and approval for the payment of remuneration to Dr. Murtaza H Khorakiwala, Managing Director of the Company. 11. Approval for the remuneration paid to Mr. Rajiv B Gandhi, Director - Corporate Finance and Information of the Company during the period January 01, 2008 to December 31, 2008. 12. Approval for the payment of remuneration to Mr. Rajiv B Gandhi, Director- Corporate Finance and Information of the Company for a period of three financial years in his tenure in which there is inadequacy or absence of profits starting from the financial year January 01, 2009. Such payment of remuneration is subject to the approval of Central Government. 13. Alteration of existing Articles of Association of the. Company by inserting clause 11A pertaining to Nominee Director. (As Per BSE Announcement Website dated on 30.06.2009) 
28-Apr-08
Wockhardt Ltd has informed BSE that the 9th Annual General Meeting (AGM) of the members of the Company will be held on April 28, 2008, inter alia, to transact the following business: 1. To receive, consider and adopt the Audited Balance Sheet as at December 31, 2007, Profit and Loss Account for the year ended on that date and the reports of the Board of Directors and Auditors thereon. 2. To declare final dividend on Equity Shares. 3. To appoint Directors in place of Mr. Shekhar Datta & Dr. B L Maheshwari, who retires by rotation and being eligible offers themselves for re-appointment. 4. To appoint auditors to hold office from the conclusion of this meeting until the conclusion of the next Annual General Meeting and to fix their remuneration. Wockhardt Ltd has informed BSE that the members at the 9th Annual General Meeting (AGM) of the Company held on April 28, 2008, inter alia, have unanimously passed the following resolutions: 1. Adoption of Audited Balance Sheet as at December 31, 2007, Profit and Loss Account for the year ended on that date and the Reports of the Board of Directors and Auditors thereon. 2. Declaration of final dividend @ 50% on the equity shares of the Company i.e. Rs 2.5 per share absorbing an amount of Rs 273.59 million. 3. Re-appointment of Mr. Shekhar Datta & Mr. B L Maheshwari as Directors of the Company. 4. Appointment of M/s. S R Batliboi, Chartered Accountants as the Statutory Auditors of the Company to hold office till the conclusion of next Annual general Meeting of the Company. (As per BSE Announcement Website dated on 29/04/2008) 
18-May-07
Wockhardt Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from May 14, 2007 to May 18, 2007 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on May 18, 2007. Wockhardt Ltd has informed BSE that the Eighth Annual General Meeting (AGM) of the members of the Company will be held on May 18, 2007, inter alia, to transact the following ordinary / special business: 1. To receive, consider and adopt the Audited Balance Sheet as at December 31, 2006, Profit and Loss Account for the year ended on that date and the Reports of the Board of Directors and Auditors thereon. 2. To appoint Directors in place of Mr. Aman Mehta and Mr. Bharat Patel, who retire by rotation and being eligible offers themselves for re-appointment. 3. To appoint auditors to hold office from the conclusion of this meeting until the conclusion of the next Annual General Meeting and to fix their remuneration. 4. To appoint Mr. Rajiv B Gandhi as Director of the Company not liable to retire by rotation. 5. Appointment of Mr. Rajiv B Gandhi as Whole-time Director of the Company, to be designated as Director - Finance & Information, for a period of 5 years with effect from February 22, 2007, on remuneration, terms & conditions. (As Per BSE Announcement Website Dated on 25/04/2007) 

EGM

19-Jan-09
Wockhardt Ltd has informed BSE that the Board has decided to convene an Extraordinary General Meeting (EGM) of the members of the Company on January 19, 2009 to consider and approve the following matters: 1. Issue of Redeemable Preference Shares of Face Value of Rs 5/- each upto Rs 500 Crores. 2. Increase in Authorised Share Capital from Rs 125 Crores to Rs 175 Crores by creation of 10 Crore preference shares of Face Value of Rs 5/- each & consequential amendments in Memorandum and Articles of Association of the Company. Wockhardt Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on January 19, 2009, inter alia, to transact the following: 1. To increase the Authorised Share Capital of the Company from Rs 1250,000,000/- (Rupees One Hundred and Twenty Five Crores) divided into 250,000,000 (Twenty Five Crores) equity shares of Rs 5/- (Rupees Five) each to Rs 1750,000,000/- (One Hundred and Seventy Five Crores) divided into 250,000,000 (Twenty Five Crores) equity shares of Rs 5/- (Rupees Five) each and 100,000,000 (Ten Crores) preference shares of Rs 5/- (Rupees Five) each by creation of 100,000,000 (Ten crores) preference shares of Rs 5/- (Rupees Five) each and consequential amendments in the Memorandum & Articles of Association of the Company. 2. To offer, issue and allot, in one or more tranches, Redeemable Preference shares of the face value of Rs 5/- (Rupees Five) each ("securities") at such price and in such numbers as the Board in its absolute discretion may decide such that the aggregate amount raised through the issue of securities does not exceed Rs 500 Crores (Rupees Five Hundred Crores Only) to Bank, Financial Institutions, Insurance Companies, Mutual funds, Bodies Corporates, Companies, Trusts. Non-Resident Indians, Overseas Corporate Bodies, Foreign Institutional Investors, Individuals or any other persons/entities or in one or more combinations thereof, whether they are members of the Company or not, through public issue, preferential allotment private placement, rights issue or any other mode and on such other terms and condition as may be decided by the Board in its absolute discretion, subject to necessary provisions & approvals. (As per BSE Announcement dated on 26/12/2008) Wockhardt Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 19, 2009, inter alia, have accorded to the following: 1. Increase in Authorised Share Capital from Rs 125 Crores to Rs 175 Crores by creation of 10 Crore preference shares of Face Value of Rs 5/- each & consequential amendments in Memorandum and Articles of Association of the Company. 2. Issue of Redeemable Preference Shares of Face Value of Rs 5/- each at such price as may be decided by the Board in its absolute discretion such that aggregate amount raised through the issue does not exceed Rs 500 Crores. (As Per BSE Announcement Website dated on 19.01.2009) 
20-Feb-08
The Board has transacted the following: Convene an extra-ordinary general meeting of the members of the Company on February 20, 2008 for obtaining the approval of shareholders to raise funds upto US$ 200 million. 
16-Mar-06
Board has approved the raising of funds upto US $ 500 million through issue of equity / equity linked securities and an Extra Ordinary General Meeting of the shareholders of the Company for the said purpose is scheduled to be convened on March 16, 2006. Wockhardt Limited has informed the Exchange that at the meeting of BoDs of the Company held on February 14, 2006, the board has recommended a dividend of Rs.5/- per equity shares, i.e. 100% for the year 2005. The company has further informed the Exchange that the Board has also approved the raising of funds upto US$ 500 million through issue of equity/equity linked securited and an EGM of the shareholders of the Company for the said purpose is scheduled to be convened on March 16, 2006. (As per NSE Bulletin dated on 14/02/2006) Wockhardt Limited has informed the Exchange regarding a press release being issued by the Company towards the outcome of EGM of shareholders held on March 16, 2006. A press release, dated, March 16, 2006, titled, "Wockhardt to raise up to $800 m to fund overseas acquisitions; EGM approves issue of equity-related instruments" (As per NSE Bulletin dated on 17/03/2006) 
20-Oct-04
EGM 20/10/2004 To obtain approval for the issue of Foreign Currency Convertible Bonds (FCCB) of US $ 100 millions plus green shoe option of US $ 10million. EGM 20/10/2004 To obtain approval for 1. To increase the borrowing powers upto a maximum limit of Rs 15000 million. m2. To raise upto USD 110 million through issue of one or more kinds of securities. 3. Converting the existing Authorised Preference Share Capital of the Company comprising of 4,00,00,000 preference Shares of Rs 10 each into 8,00,00,000 equity shares of Rs 5 each. (As per BSE Bulletin dated on 05/10/2004) Wockhardt Limited has informed the Exchange that an EGM is scheduled on October 20, 2004 for approval of shareholders with regard to issue of Foreign Currency Convertible Bonds. (As per NSE Bulletin dated on 05/10/2004) The Company has informed that at the Extraordinary General Meeting of the Company held on October 20, 2004 members have approved the issue of Foreign Currency Convertible Bonds (FCCB) of US $ 110 million. (AS per BSE Bulletin dated on 20/10/2004) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 59,024.02 36.91 8.84 29.33 22.3 23.3 0.01
Dr Reddy's Labs 28,898.96 31.67 4.30 22.23 15.0 15.2 0.17
Cipla 24,889.90 22.14 3.32 18.79 15.4 17.9 0.04
Ranbaxy Labs. 22,222.51 17.79 11.55 0.00 0.0 0.0 1.22
Cadila Health. 15,284.86 23.25 6.00 21.79 32.9 27.5 0.31
Glenmark Pharma. 9,637.92 36.32 4.41 24.56 11.3 11.9 0.51
Wockhardt 8,617.31 29.96 71.71 39.85 0.0 0.0 3.18
Piramal Health 7,302.32 55.83 0.66 0.33 4.2 6.1 0.07
Torrent Pharma. 5,414.83 14.93 4.15 11.43 29.5 25.9 0.55
Biocon 4,322.00 16.91 2.06 11.21 26.2 26.8 0.10
Ipca Labs. 4,270.28 15.69 4.05 10.26 26.5 25.1 0.51
Strides Arcolab 3,982.81 61.55 2.94 16.20 5.1 5.7 0.97
Aurobindo Pharma 3,357.84 10.43 1.31 8.01 26.5 19.7 0.95
Matrix Labs. 3,273.19 8.13 2.00 0.00 28.9 27.4 0.52
Fres.Kabi Onco. 2,187.12 83.79 4.04 16.45 9.5 10.8 0.58

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Habil F Khorakiwala , Chairman 

Shekhar Datta , Director 

Abid Hussain , Director 

R A Shah , Director 


Company Head Office / Quarters:
Wockhardt Towers,
Bandra Kurla Complex Bandra-E,
Mumbai,
Maharashtra-400051
Phone : 91-22-26534444
Fax : 91-22-26534242
E-mail : investorrelations@wockhardt.com
Web : http://www.wockhardt.com
Registrars:
Link Intime India Pvt Ltd
C-13 Pannalal Silk
Mills Cmpd LBS Marg
Bhandup West
Mumbai - 400 078

Fund Holding

 
Scheme Name No. of Shares
AXIS Midcap Fund (G) 68,658

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
IPO
listNo IPO today
Economic Events
list U. of Michigan Confidence
list Italian Hourly Wages (MoM)
Results
list Reliance Infra. | Crompton Greaves | ITC | Guj Fluorochem